HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeru Funakoshi Selected Research

Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)

11/2019Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeru Funakoshi Research Topics

Disease

25Neoplasms (Cancer)
10/2023 - 09/2015
20Melanoma (Melanoma, Malignant)
08/2023 - 01/2015
8Extramammary Paget Disease (Paget Disease, Extramammary)
01/2024 - 10/2017
5Neoplasm Metastasis (Metastasis)
12/2021 - 01/2015
4Fever (Fevers)
08/2022 - 01/2018
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 03/2017
3Stomach Neoplasms (Stomach Cancer)
08/2023 - 01/2020
3Pemphigus (Pemphigus Vulgaris)
02/2023 - 07/2017
3Testicular Neoplasms (Testicular Cancer)
01/2023 - 10/2015
2Renal Cell Carcinoma (Grawitz Tumor)
08/2023 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 01/2020
2Pneumonia (Pneumonitis)
08/2023 - 02/2023
2Erythema Multiforme
01/2023 - 07/2017
2Rheumatoid Arthritis
01/2023 - 02/2014
2Ulcerative Colitis
01/2023 - 03/2021
2Skin Diseases (Skin Disease)
09/2021 - 12/2010
2Linear IgA Bullous Dermatosis
09/2021 - 01/2018
2Disease Progression
03/2020 - 01/2018
1Porokeratosis (Palmoplantar Porokeratosis)
04/2024
1Skin Neoplasms (Skin Cancer)
04/2024
1Radius Fractures (Radius Fracture)
02/2023
1Heart Failure
02/2023
1Osteonecrosis (Kienbock's Disease)
02/2023
1Basal Cell Carcinoma (Rodent Ulcer)
09/2022
1Erythema
08/2022
1Diarrhea
08/2022
1Hydronephrosis
08/2022
1Lymphadenopathy
08/2022
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2022
1Hypertriglyceridemia
02/2022
1Mycosis Fungoides
02/2022
1Hypercholesterolemia
02/2022
1Neutropenia
02/2022
1Rare Diseases (Rare Disease)
09/2021
1Blister (Bulla)
09/2021
1Respiratory Insufficiency (Respiratory Failure)
09/2021
1Leukopenia
08/2021
1Enterocolitis
03/2021
1Bites and Stings (Sting)
01/2021
1Shock
12/2020
1Anaphylaxis (Anaphylactic Shock)
12/2020

Drug/Important Bio-Agent (IBA)

12NivolumabIBA
08/2023 - 11/2016
7Immune Checkpoint InhibitorsIBA
08/2023 - 01/2019
5pembrolizumabIBA
08/2023 - 01/2018
4AntigensIBA
01/2023 - 10/2015
4IpilimumabIBA
01/2023 - 07/2017
4AntibodiesIBA
01/2020 - 01/2018
4Biomarkers (Surrogate Marker)IBA
11/2019 - 01/2018
4Epirubicin (Ellence)FDA LinkGeneric
01/2019 - 09/2015
3Rituximab (Mabthera)FDA Link
02/2023 - 07/2017
3mogamulizumabIBA
01/2023 - 10/2015
3AutoantibodiesIBA
09/2021 - 10/2015
3Monoclonal AntibodiesIBA
10/2020 - 11/2016
3Programmed Cell Death 1 ReceptorIBA
01/2019 - 11/2016
3Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2017
3Carboplatin (JM8)FDA LinkGeneric
07/2018 - 09/2015
2Androgen Receptors (Androgen Receptor)IBA
10/2023 - 09/2023
2atezolizumabIBA
08/2023 - 01/2020
2Immunoglobulin G (IgG)IBA
02/2023 - 02/2019
2Immunoglobulin A (IgA)IBA
09/2021 - 01/2018
2Small Interfering RNA (siRNA)IBA
01/2021 - 01/2015
2Docetaxel (Taxotere)FDA Link
06/2020 - 04/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2019 - 10/2017
1Mevalonic Acid (Mevalonate)IBA
04/2024
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2024
1eribulinFDA Link
01/2024
1AndrogensIBA
10/2023
1DesmogleinsIBA
02/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023
1Janus Kinase InhibitorsIBA
01/2023
15-((glucopyranosyloxy)methyl)uracilIBA
09/2022
1Zonisamide (Zonegran)FDA LinkGeneric
08/2022
1Bexarotene (LGD1069)FDA Link
02/2022
1Surface Antigens (Surface Antigen)IBA
01/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2021
1Imatinib Mesylate (Gleevec)FDA Link
12/2021
1Indicators and Reagents (Reagents)IBA
11/2021
1Secretory Immunoglobulin A (SIgA)IBA
09/2021
1ChemokinesIBA
08/2021
1CateninsIBA
08/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021
1Capsules (Microcapsules)IBA
03/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1SugammadexIBA
12/2020
1Rocuronium (Zemuron)FDA LinkGeneric
12/2020

Therapy/Procedure

20Therapeutics
02/2023 - 11/2016
8Drug Therapy (Chemotherapy)
04/2024 - 09/2015
8Immunotherapy
01/2023 - 06/2017
1Perioperative Period
12/2022
1Stents
08/2022
1Lymph Node Excision (Lymph Node Dissection)
12/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2021
1ACT regimen
08/2021
1General Anesthesia
12/2020
1Tracheostomy
12/2020
1Cardiopulmonary Resuscitation (CPR)
12/2020
1Anesthesia
12/2020